X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (973) 973
humans (889) 889
female (628) 628
oncology (625) 625
cancer (458) 458
middle aged (324) 324
aged (296) 296
chemotherapy (243) 243
adult (228) 228
obstetrics & gynecology (218) 218
endometrial cancer (198) 198
animals (187) 187
carcinoma (166) 166
care and treatment (161) 161
advanced solid tumors (159) 159
pharmacology & pharmacy (158) 158
male (153) 153
neoplasm staging (142) 142
research (131) 131
treatment outcome (131) 131
advanced breast-cancer (130) 130
aged, 80 and over (129) 129
antineoplastic agents - therapeutic use (129) 129
health aspects (126) 126
tumors (126) 126
prognosis (124) 124
medicine & public health (123) 123
neoplasms - drug therapy (122) 122
surgery (116) 116
analysis (115) 115
hematology, oncology and palliative medicine (110) 110
gynecologic-oncology-group (107) 107
survival (104) 104
advanced basic science (103) 103
ovarian cancer (103) 103
radiotherapy (100) 100
endometrial neoplasms - pathology (94) 94
phase-ii trial (94) 94
metastasis (93) 93
radiology, nuclear medicine & medical imaging (93) 93
retrospective studies (91) 91
antineoplastic combined chemotherapy protocols - therapeutic use (90) 90
cell lung-cancer (90) 90
breast cancer (88) 88
phase-iii trial (88) 88
advanced cervical-cancer (86) 86
cell biology (85) 85
breast-cancer (82) 82
clinical trials (82) 82
breast neoplasms - drug therapy (81) 81
cervical cancer (74) 74
postmenopausal women (74) 74
obstetrics and gynecology (72) 72
therapy (71) 71
endometrial neoplasms - drug therapy (70) 70
disease-free survival (68) 68
expression (68) 68
advanced ovarian-cancer (67) 67
cisplatin (66) 66
clinical trials as topic (65) 65
antineoplastic agents - pharmacology (63) 63
survival rate (63) 63
cancer therapies (62) 62
antineoplastic agents (61) 61
review (61) 61
article (60) 60
drug therapy (59) 59
antimitotic agents (58) 58
genetic aspects (57) 57
ovarian neoplasms - pathology (57) 57
women (57) 57
biochemistry & molecular biology (56) 56
cancer research (56) 56
squamous-cell carcinoma (56) 56
tamoxifen (56) 56
apoptosis (55) 55
combined modality therapy (55) 55
development and progression (55) 55
radiation-therapy (54) 54
neoplasms - pathology (53) 53
patients (53) 53
follow-up studies (52) 52
paclitaxel (52) 52
advanced endometrial carcinoma (51) 51
medical research (51) 51
ovarian neoplasms - drug therapy (51) 51
mutation (50) 50
mice (49) 49
neoplasms - metabolism (48) 48
hematology (47) 47
oncology, experimental (47) 47
chemotherapy, adjuvant (46) 46
pharmacology/toxicology (46) 46
proteins (46) 46
randomized-trial (46) 46
abridged index medicus (45) 45
endometrial carcinoma (45) 45
prostate-cancer (45) 45
antineoplastic agents - adverse effects (44) 44
cell line, tumor (44) 44
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, ISSN 0392-2936, 2019, Volume 40, Issue 4, pp. 614 - 618
Objectives: Four to six percent of endometrial cancer (EC) cases have been diagnosed at an advanced stage. The aim of the study is to show the role of... 
Immunohistochemistry | SURVIVAL | MELF PATTERN | Endometrial cancer | ADENOCARCINOMAS | Endometriosis | CYTOLOGY | MLH1 | CANCER | p53 | OBSTETRICS & GYNECOLOGY | INVASION | P16 | ONCOLOGY | SEROUS CARCINOMA | Advanced stage | GRADE | EXPRESSION
Journal Article
Journal Article
Journal Article
European Journal of Obstetrics and Gynecology, ISSN 0301-2115, 09/2017, Volume 216, pp. 192 - 197
Para-aortic lymph node involvement in women with endometrial carcinoma (EC) is a poor prognostic factor. Many studies have included women with stage IIIC in... 
Recurrence | Advanced stage | Prognosis | Endometrial carcinoma | Stage IIIC2 | Survival | Stage IIIC | ADJUVANT CHEMOTHERAPY | MULTICENTER | METASTASIS | METAANALYSIS | GYNECOLOGIC-ONCOLOGY-GROUP | PELVIC LYMPH-NODES | OBSTETRICS & GYNECOLOGY | TRIAL | REPRODUCTIVE BIOLOGY | CANCER-PATIENTS | RADIOTHERAPY | POSTOPERATIVE RADIATION-THERAPY | Index Medicus
Journal Article
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2008, Volume 112, Issue 3, pp. 543 - 552
Journal Article
Anticancer Research, ISSN 0250-7005, 05/2012, Volume 32, Issue 5, pp. 1817 - 1820
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2004, Volume 92, Issue 1, pp. 10 - 14
Journal Article
Gynecologic Oncology, ISSN 0090-8258, 2015, Volume 138, Issue 1, pp. 165 - 173
Abstract Objectives Endometrial carcinoma (EC) is the most common gynecological cancer in the Western World. Treatment options are limited for advanced and... 
Hematology, Oncology and Palliative Medicine | Obstetrics and Gynecology | NVP-BEZ235 | Endometrioid endometrial cancer | Targeted therapy | AZD6244 | Primary cell culture | MUTATED COLORECTAL-CANCER | ADVANCED SOLID TUMORS | SELUMETINIB AZD6244 | I PI3K INHIBITOR | PHASE-II | ANTITUMOR-ACTIVITY | OBSTETRICS & GYNECOLOGY | DOSE-ESCALATION | UVEAL MELANOMA | ONCOLOGY | PI3-KINASE INHIBITOR | BUPARLISIB BKM120 | TOR Serine-Threonine Kinases - metabolism | raf Kinases - antagonists & inhibitors | Humans | Imidazoles - administration & dosage | ras Proteins - metabolism | Phosphatidylinositol 3-Kinases - metabolism | Phosphatidylinositol 3-Kinases - antagonists & inhibitors | Quinolines - administration & dosage | raf Kinases - metabolism | Quinolines - pharmacology | Antineoplastic Combined Chemotherapy Protocols - pharmacology | TOR Serine-Threonine Kinases - antagonists & inhibitors | Benzimidazoles - administration & dosage | Female | Tumor Cells, Cultured | MAP Kinase Kinase Kinases - antagonists & inhibitors | Proto-Oncogene Proteins c-akt - metabolism | Endometrial Neoplasms - enzymology | Carcinoma, Endometrioid - enzymology | ras Proteins - antagonists & inhibitors | Imidazoles - pharmacology | Carcinoma, Endometrioid - drug therapy | Drug Synergism | Xenograft Model Antitumor Assays | Animals | MAP Kinase Signaling System - drug effects | Benzimidazoles - pharmacology | Endometrial Neoplasms - drug therapy | Mice | Proto-Oncogene Proteins c-akt - antagonists & inhibitors | Carcinoma | Cancer | Index Medicus
Journal Article
Journal Article
Journal Article
Journal Article